Aminosalicylate [EPC] — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the aminosalicylate [epc] class. 4 active patents protecting 1 drugs. First major cliff: 2027. Daily refresh.

1
Drugs in class
4
Active US patents
54/100
Avg vulnerability
—
Annual revenue covered

Originators

Cliff calendar — next 15 years

1
27
2
28
1
30

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
MESALAMINE — 4 54 — 2027-07-24

Most attackable patents

Patent Drug Type Vuln Expiry
8865688 MESALAMINE method of use 73 2030-05-01
8217083 MESALAMINE formulation 60 2028-06-06
8436051 MESALAMINE formulation 60 2028-06-06
7645801 MESALAMINE composition of matter 22 2027-07-24

Strongest defences

Patent Drug Type Vuln Expiry
7645801 MESALAMINE composition of matter 22 2027-07-24
8217083 MESALAMINE formulation 60 2028-06-06
8436051 MESALAMINE formulation 60 2028-06-06
8865688 MESALAMINE method of use 73 2030-05-01

Related